MicroRNA miR-145-5p Inhibits Cutaneous Wound Healing by Targeting PDGFD in Diabetic Foot Ulcer

被引:4
|
作者
Wang, Chun [1 ,2 ]
Huang, Li [3 ]
Li, Juan [4 ]
Liu, Dan [4 ]
Wu, Biaoliang [1 ,5 ]
机构
[1] Jinan Univ, Guangzhou 510632, Peoples R China
[2] Bengbu Med Coll, Dept Gen Med, Affiliated Hosp 2, Bengbu 233040, Peoples R China
[3] Bengbu Med Coll, Dept Pathophysiol, Bengbu 233030, Peoples R China
[4] Bengbu Med Coll, Dept Endocrinol, Affiliated Hosp 2, Bengbu 233040, Peoples R China
[5] Youjiang Med Univ Nationalities, Dept Endocrinol, Affiliated Hosp, 18 Zhongshan Second Rd, Baise City 533000, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Diabetic foot ulcer; Fibroblasts; miR-145-5p; PDGFD; Wound healing; MECHANISM; MELLITUS; MIR-21; EGFR;
D O I
10.1007/s10528-023-10551-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic foot ulcer (DFU) is one major, common and serious chronic complication of diabetes mellitus, which is characterized by high incidence, high risk, high burden, and high treatment difficulty and is a leading cause of disability and death in patients with diabetes. Long-term hyperglycemia can result in cellular dysfunction of fibroblasts, which play pivotal roles in wound healing. MicroRNAs (miRNAs) were reported to mediate the pathological processes of multiple diseases, including diabetic wound healing. This research aimed to investigate the functional role of miR-145-5p in high-glucose (HG)-exposed fibroblasts and in DFU mouse models. Human foreskin fibroblast cells (HFF-1) were stimulated by HG to induce cell injury. MiR-145-5p level in HG-stimulated HFF-1 cells was detected via RT-qPCR. The binding between miR-145-5p and PDGFD was validated by Luciferase reporter assay. The effects of the miR-145-5p/PDGFD axis on the viability, migration, and apoptosis of HG-exposed HFF-1 cells were determined by CCK-8, wound healing, and flow cytometry assays. DFU mouse models were subcutaneously injected at the wound edges with miR-145-5p inhibitor/mimics. Images of the wounds were captured on day 0 and 8 post-injection, and wound samples were collected after mice were sacrificed for histological analysis by H&E staining. HG decreased cell viability and increased miR-145-5p expression in HFF-1 cells in a dose- and time-dependent manner. MiR-145-5p downregulation promoted cell viability and migration and inhibited cell apoptosis of HG-stimulated HFF-1 cells, while miR-145-5p overexpression exerted an opposite effect on cell viability, migration, and apoptosis. PDGFD was a direct target gene of miR-145-5p, whose silencing reversed the influence of miR-145-5p downregulation on HG-induced cellular dysfunction of HFF-1 cells. Additionally, downregulating miR-145-5p facilitated while overexpressing miR-145-5p inhibited wound healing in DFU mouse models. MiR-145-5p level was negatively associated with PDGFD level in wound tissue samples of DFU mouse models. MiR-145-5p inhibition improves wound healing in DFU through upregulating PDGFD expression.
引用
收藏
页码:2437 / 2454
页数:18
相关论文
共 50 条
  • [31] Insights into remyelination failure in progressive multiple sclerosis - microRNA miR-145-5p negatively regulates myelination
    Kornfeld, S.
    Bonin, S.
    Cummings, S.
    Fathi, S.
    Kothary, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 610 - 610
  • [32] Ultrasound Microbubble-Stimulated miR-145-5p Inhibits Malignant Behaviors of Breast Cancer Cells by Targeting ACTG1
    Ren, Liang
    Wang, Li
    Yi, Xuelin
    Tan, Yang
    Yi, Lingxian
    He, Jinlan
    Li, Danping
    ULTRASOUND QUARTERLY, 2024, 40 (02) : 136 - 143
  • [33] Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1
    Gao, Wei
    Zhang, Chunming
    Li, Wenqi
    Li, Huizheng
    Sang, Jiangwei
    Zhao, Qinli
    Bo, Yunfeng
    Luo, Hongjie
    Zheng, Xiwang
    Lu, Yan
    Shi, Yong
    Yang, Dongli
    Zhang, Ruiping
    Li, Zhenyu
    Cui, Jiajia
    Zhang, Yuliang
    Niu, Min
    Li, Jun
    Wu, Zhongqiang
    Guo, Huina
    Xiang, Caixia
    Wang, Juan
    Hou, Juan
    Zhang, Lu
    Thorne, Rick F.
    Cui, Yongping
    Wu, Yongyan
    Wen, Shuxin
    Wang, Binquan
    MOLECULAR THERAPY, 2019, 27 (02) : 365 - 379
  • [34] MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16
    Wu, Junbiao
    He, Yu
    Luo, Yining
    Zhang, Lei
    Lin, Hua
    Liu, Xusheng
    Liu, Bihao
    Liang, Chunling
    Zhou, Yuan
    Zhou, Jiuyao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (04) : 3648 - 3659
  • [35] Participation of MiR-145-5p in Neuronal Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor-5
    Xu, Lei
    Chen, Yaqi
    Wu, Jing
    Li, Jie
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2023, 24 (01) : 63 - 72
  • [36] MiR-145-5p Inhibits the Invasion of Prostate Cancer and Induces Apoptosis by Inhibiting WIP1
    Sun, Jianming
    Deng, Linggang
    Gong, Ye
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [37] PDZK1 regulated by miR-145-5p protects against endothelial cell apoptosis and diabetic retinopathy by targeting mitochondrial function
    An, Meixia
    Huang, Jialuo
    Zhao, Jian
    Wang, Lili
    Liu, Yanli
    EXPERIMENTAL EYE RESEARCH, 2025, 254
  • [38] Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma
    Mataki, Hiroko
    Seki, Naohiko
    Mizuno, Keiko
    Nohata, Nijiro
    Kamikawaji, Kazuto
    Kumamoto, Tomohiro
    Koshizuka, Keiichi
    Goto, Yusuke
    Inoue, Hiromasa
    ONCOTARGET, 2016, 7 (44) : 72084 - 72098
  • [39] Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) are involved in castration-resistant prostate cancer pathogenesis
    Kato, Mayuko
    Kurozumi, Akira
    Goto, Yusuke
    Nohata, Nijiro
    Arai, Takayuki
    Okato, Atsushi
    Koshizuka, Keiichi
    Kojima, Satoko
    Ichikawa, Tomohiko
    Seki, Naohiko
    CANCER RESEARCH, 2017, 77
  • [40] miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3
    Chen, Qing
    Zhou, Lin
    Ye, Xia
    Tao, Min
    Wu, Jie
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)